Prognostic implications of the European consensus for grading of bone marrow fibrosis in chronic idiopathic myelofibrosis

Claudia Vener, Nicola Stefano Fracchiolla, Umberto Gianelli, +6

Blood

Relationship between autoimmune phenomena and disease stage and therapy in B-cell chronic lymphocytic leukemia.

Wilma Barcellini, Silvana Capalbo, Rosa Maria Agostinelli, +11

PubMed

Mixed-phenotype Acute LeukemiaImmunologyPathologyDisease StageImmunotherapy +16

Analysis of alterations of oncogenes and tumor suppressor genes in chronic lymphocytic leukemia.

Gianluca Gaïdano, Elizabeth W. Newcomb, Jerry Z. Gong, +6

PubMed

VEGF Expression Correlates With Microvessel Density in Philadelphia Chromosome–Negative Chronic Myeloproliferative Disorders

Umberto Gianelli, Claudia Vener, Paola Rafaniello Raviele, +10

American Journal of Clinical Pathology

Hematological MalignancyThrombosisBone Marrow FailureMicrovessel DensityMalignant Blood Disorder +13

CD34 immunohistochemistry of bone marrow biopsies: Prognostic significance in primary myelodysplastic syndromes

Davide Soligo, Alessandro Oriani, C. Annaloro, +5

American Journal of Hematology

Differential expression of very late activation antigen-3 (VLA-3)/VLA-4 in B-cell non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia

Luca Baldini, Lilla Cro, Rossella Calori, +3

Blood

Second malignancies in essential thrombocythemia (ET): a retrospective analysis of 331 patients with long-term follow-up from a single institution

Franca Radaelli, Francesco Onida, Francesca Gaia Rossi, +4

Hematology

Differential expression of very late activation antigen-3 (VLA-3)/VLA-4 in B-cell non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia

Luca Baldini, Lilla Cro, Rossella Calori, +3

Blood

In vitro production of anti‐RBC antibodies and cytokines in chronic lymphocytic leukemia

Wilma Barcellini, Rosanna Montesano, Giacomo Clerici, +5

American Journal of Hematology

Chronic Lymphocytic LeukemiaImmunologyBlood CellPathologyImmunotherapy +15

Analysis of risk factors predicting thrombotic and/or haemorrhagic complications in 306 patients with Essential Thrombocythemia

Franca Radaelli, Rossella Calori, Vittorio Ruggero Zilioli, +3

Hematological Oncology

Essential ThrombocythemiaConsecutive Et PatientsThrombosisVenous ThrombosisStroke +18